Both in Pharmaceuticals
Lexicon Pharmaceuticals vs Design Therapeutics
Over the past year LXRX returned +5.9% and DSGN returned +55.0%; their daily moves had a correlation of 0.19.
LXRX +5.9% DSGN +55.0%Growth of $1, one year, split-adjusted
| Metric | LXRX | DSGN |
|---|---|---|
| Price | $1.44 | $10.15 |
| Market cap | $640.7M | $635.2M |
| Today | +1.41% | −4.96% |
| 1 month | −20.9% | −17.7% |
| 6 months | −10.0% | −22.9% |
| Year to date | +25.2% | +8.2% |
| 1 year | +7.5% | +55.4% |
| Revenue growth (YoY) | −97.6% | — |
| Gross margin | 94.4% | — |
| Net margin | −4591.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 15.5× | — |
| Net cash | $139.2M | $207.4M |
| Dividend yield | — | — |
| Volatility (60d) | 51.9% | 55.4% |
| Short % of float | 11.8% | 21.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).